Literature DB >> 26667167

The Costimulatory Molecule ICOS Regulates Host Th1 and Follicular Th Cell Differentiation in Response to Plasmodium chabaudi chabaudi AS Infection.

Daniel J Wikenheiser1, Debopam Ghosh1, Brian Kennedy1, Jason S Stumhofer2.   

Abstract

Blood-stage Plasmodium chabaudi chabaudi AS infection requires cell- and Ab-mediated immunity to control acute and persistent infection, respectively. ICOS regulates CD4(+) T cell activation and promotes the induction of follicular Th (TFH) cells, CD4(+) T cells that support B cell affinity maturation within germinal centers (GCs), resulting in the production of high-affinity Abs. In this article, we demonstrate that, in response to P. c. chabaudi AS infection, the absence of ICOS resulted in an enhanced Th1 immune response that reduced peak parasitemia. Despite the absence of ICOS, CD4(+) T cells were capable of expressing PD-1, B cell lymphoma 6, and CXCR5 during early infection, indicating TFH development was not impaired. However, by day 21 postinfection, Icos(-/-) mice accumulated fewer splenic TFHs compared with Icos(+/+) mice, leading to substantially fewer GC B cells and a decrease in affinity, but not production, of parasite-specific isotype-switched Abs. Moreover, treatment of mice with anti-ICOS ligand Abs to modulate ICOS-ICOS ligand signaling revealed a requirement for ICOS in TFH differentiation only after day 6 postinfection. Ultimately, the quality and quantity of isotype-switched Abs produced in Icos(-/-) mice declined over time, resulting in impaired control of persistent parasitemia. Collectively, these data suggest ICOS is not required for TFH induction during P. c. chabaudi AS infection or production of isotype-switched Abs, but it is necessary for maintenance of a sustained high-affinity, protective Ab response.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26667167      PMCID: PMC4705592          DOI: 10.4049/jimmunol.1403206

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  66 in total

1.  The CD28-related molecule ICOS is required for effective T cell-dependent immune responses.

Authors:  A J Coyle; S Lehar; C Lloyd; J Tian; T Delaney; S Manning; T Nguyen; T Burwell; H Schneider; J A Gonzalo; M Gosselin; L R Owen; C E Rudd; J C Gutierrez-Ramos
Journal:  Immunity       Date:  2000-07       Impact factor: 31.745

2.  ICOS is essential for effective T-helper-cell responses.

Authors:  A Tafuri; A Shahinian; F Bladt; S K Yoshinaga; M Jordana; A Wakeham; L M Boucher; D Bouchard; V S Chan; G Duncan; B Odermatt; A Ho; A Itie; T Horan; J S Whoriskey; T Pawson; J M Penninger; P S Ohashi; T W Mak
Journal:  Nature       Date:  2001-01-04       Impact factor: 49.962

3.  ICOS is critical for CD40-mediated antibody class switching.

Authors:  A J McAdam; R J Greenwald; M A Levin; T Chernova; N Malenkovich; V Ling; G J Freeman; A H Sharpe
Journal:  Nature       Date:  2001-01-04       Impact factor: 49.962

4.  ICOS co-stimulatory receptor is essential for T-cell activation and function.

Authors:  C Dong; A E Juedes; U A Temann; S Shresta; J P Allison; N H Ruddle; R A Flavell
Journal:  Nature       Date:  2001-01-04       Impact factor: 49.962

5.  A role for inducible costimulator protein in the CD28- independent mechanism of resistance to Toxoplasma gondii.

Authors:  Eric N Villegas; Linda A Lieberman; Nicola Mason; Sarah L Blass; Valerie P Zediak; Robert Peach; Tom Horan; Steve Yoshinaga; Christopher A Hunter
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

6.  Evolution of autoantibody responses via somatic hypermutation outside of germinal centers.

Authors:  Jacqueline William; Chad Euler; Sean Christensen; Mark J Shlomchik
Journal:  Science       Date:  2002-09-20       Impact factor: 47.728

7.  Cutting edge: inducible costimulator protein regulates both Th1 and Th2 responses to cutaneous leishmaniasis.

Authors:  Rebecca J Greenwald; Alexander J McAdam; Diane Van der Woude; Abhay R Satoskar; Arlene H Sharpe
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

8.  Cutting edge: critical role of inducible costimulator in germinal center reactions.

Authors:  C Dong; U A Temann; R A Flavell
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

9.  Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells.

Authors:  A J McAdam; T T Chang; A E Lumelsky; E A Greenfield; V A Boussiotis; J S Duke-Cohan; T Chernova; N Malenkovich; C Jabs; V K Kuchroo; V Ling; M Collins; A H Sharpe; G J Freeman
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

10.  Expression of ICOS in vivo defines CD4+ effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10.

Authors:  Max Löhning; Andreas Hutloff; Tilmann Kallinich; Hans Werner Mages; Kerstin Bonhagen; Andreas Radbruch; Eckard Hamelmann; Richard A Kroczek
Journal:  J Exp Med       Date:  2003-01-20       Impact factor: 14.307

View more
  26 in total

1.  Development of a Novel CD4+ TCR Transgenic Line That Reveals a Dominant Role for CD8+ Dendritic Cells and CD40 Signaling in the Generation of Helper and CTL Responses to Blood-Stage Malaria.

Authors:  Daniel Fernandez-Ruiz; Lei Shong Lau; Nazanin Ghazanfari; Claerwen M Jones; Wei Yi Ng; Gayle M Davey; Dorothee Berthold; Lauren Holz; Yu Kato; Matthias H Enders; Ganchimeg Bayarsaikhan; Sanne H Hendriks; Lianne I M Lansink; Jessica A Engel; Megan S F Soon; Kylie R James; Anton Cozijnsen; Vanessa Mollard; Alessandro D Uboldi; Christopher J Tonkin; Tania F de Koning-Ward; Paul R Gilson; Tsuneyasu Kaisho; Ashraful Haque; Brendan S Crabb; Francis R Carbone; Geoffrey I McFadden; William R Heath
Journal:  J Immunol       Date:  2017-10-30       Impact factor: 5.422

2.  Th1-like Plasmodium-Specific Memory CD4+ T Cells Support Humoral Immunity.

Authors:  Ryan A Zander; Rahul Vijay; Angela D Pack; Jenna J Guthmiller; Amy C Graham; Scott E Lindner; Ashley M Vaughan; Stefan H I Kappe; Noah S Butler
Journal:  Cell Rep       Date:  2017-11-14       Impact factor: 9.423

Review 3.  Co-stimulatory and co-inhibitory pathways in cancer immunotherapy.

Authors:  Rachel E O'Neill; Xuefang Cao
Journal:  Adv Cancer Res       Date:  2019-04-17       Impact factor: 6.242

4.  ICOS Expression Is Required for Maintenance but Not the Formation of Germinal Centers in the Spleen in Response to Plasmodium yoelii Infection.

Authors:  Kara A O'Neal; Leah E Latham; Enatha Ntirandekura; Camille L Foscue; Jason S Stumhofer
Journal:  Infect Immun       Date:  2022-01-10       Impact factor: 3.609

5.  Th1-like Plasmodium-Specific Memory CD4+ T Cells Support Humoral Immunity.

Authors:  Ryan A Zander; Rahul Vijay; Angela D Pack; Jenna J Guthmiller; Amy C Graham; Scott E Lindner; Ashley M Vaughan; Stefan H I Kappe; Noah S Butler
Journal:  Cell Rep       Date:  2018-04-24       Impact factor: 9.423

Review 6.  Using two phases of the CD4 T cell response to blood-stage murine malaria to understand regulation of systemic immunity and placental pathology in Plasmodium falciparum infection.

Authors:  Komi Gbedande; Victor H Carpio; Robin Stephens
Journal:  Immunol Rev       Date:  2020-01       Impact factor: 12.988

7.  Evolution of pathologic T-cell subsets in patients with atopic dermatitis from infancy to adulthood.

Authors:  Tali Czarnowicki; Helen He; Talia Canter; Joseph Han; Rachel Lefferdink; Taylor Erickson; Stephanie Rangel; Naoya Kameyama; Hyun Je Kim; Ana B Pavel; Yeriel Estrada; James G Krueger; Amy S Paller; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2019-10-15       Impact factor: 10.793

Review 8.  T cell-mediated immunity to malaria.

Authors:  Noah S Butler; John T Harty; Samarchith P Kurup
Journal:  Nat Rev Immunol       Date:  2019-07       Impact factor: 53.106

9.  IFNAR1-Signalling Obstructs ICOS-mediated Humoral Immunity during Non-lethal Blood-Stage Plasmodium Infection.

Authors:  Ismail Sebina; Kylie R James; Megan S F Soon; Lily G Fogg; Shannon E Best; Fabian de Labastida Rivera; Marcela Montes de Oca; Fiona H Amante; Bryce S Thomas; Lynette Beattie; Fernando Souza-Fonseca-Guimaraes; Mark J Smyth; Paul J Hertzog; Geoffrey R Hill; Andreas Hutloff; Christian R Engwerda; Ashraful Haque
Journal:  PLoS Pathog       Date:  2016-11-03       Impact factor: 6.823

Review 10.  ICOS Co-Stimulation: Friend or Foe?

Authors:  Daniel J Wikenheiser; Jason S Stumhofer
Journal:  Front Immunol       Date:  2016-08-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.